Company information:
Seres Therapeutics Uk Limited (No: 09634061)
Address: INTERTRUST UK, 1 BARTHOLOMEW LANE, LONDON, EC2N 2AX, UNITED KINGDOM
Status: Active
Incorporated: 06-Nov-2015
Accounts Next Due: 30-Sep-2024
Next Confirmation Statement Due: 19-Jul-2024
Industry Class: 72110 - Research and experimental development on biotechnology
Current Director: DAVID ARKOWITZ ( DOB: Oct-1961 From: Apr-2022 )
Current Secretary: 7SIDE SECRETARIAL LTD ( From: Jun-2015 )
Current Secretary: INTERTRUST (UK) LIMITED ( From: Sep-2023 )
Current Secretary: INTERTRUST (UK) LIMITED ( From: Sep-2023 )
Resigned Director: MARCUS ANDREW CHAPMAN ( DOB: Nov-1970 From: Dec-2018 To: Apr-2022 )
Resigned Director: MARCUS ANDREW CHAPMAN ( DOB: Nov-1970 From: Dec-2018 To: Apr-2022 )
Resigned Director: THOMAS KOTARAKOS ( From: Jun-2015 To: Dec-2018 )
Resigned Secretary: DYE & DURHAM SECRETARIAL LIMITED ( From: Jun-2015 To: May-2023 )
Persons of Significant Control:
Ph.D Noubar B. Afeyan, 55 Cambridge Parkway, Suite 800e, Cambridge, Massachusetts, 02142, United States: Ownership of voting rights - More than 25% but not more than 50% (Notified: 2016-04-06, Ceased: 2020-08-12)
Company Accounts Summary (£)
Item | 16 | 17 | 18 | 19 | 21 | 22 | 23 | Chart |
---|---|---|---|---|---|---|---|---|
Called up share capital not paid, not expressed as current asset | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1.0,1.0,1.0,1.0,1.0,1.0,1.0 |
Fixed assets | 0.0,0.0,0.0,0.0,0.0,0.0,0.0 | |||||||
Current assets | 18,602 | 15,765 | 9,150 | 6,283 | 560 | 7,871 | 4,971 | 18602.0,15765.0,9150.0,6283.0,560.0,7871.0,4971.0 |
Prepayments and accrued income, not expressed within current asset subtotal | 0.0,0.0,0.0,0.0,0.0,0.0,0.0 | |||||||
Net current assets (liabilities) | 18,602 | 15,765 | 9,150 | 6,283 | 560 | 7,871 | 4,971 | 18602.0,15765.0,9150.0,6283.0,560.0,7871.0,4971.0 |
Total assets less current liabilities | 18,603 | 15,766 | 9,151 | 6,284 | 561 | 7,872 | 4,972 | 18603.0,15766.0,9151.0,6284.0,561.0,7872.0,4972.0 |
Provisions for liabilities, balance sheet subtotal | 0.0,0.0,0.0,0.0,0.0,0.0,0.0 | |||||||
Accrued liabilities, not expressed within creditors subtotal | 0.0,0.0,0.0,0.0,0.0,0.0,0.0 | |||||||
Net assets (liabilities) | 18,603 | 15,766 | 9,151 | 6,284 | 561 | 7,872 | 4,972 | 18603.0,15766.0,9151.0,6284.0,561.0,7872.0,4972.0 |
Equity / share capital and reserves | 18,603 | 15,766 | 9,151 | 6,284 | 561 | 7,872 | 4,972 | 18603.0,15766.0,9151.0,6284.0,561.0,7872.0,4972.0 |